Literature DB >> 27823692

Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).

Favel L Mondesir1, Todd M Brown2, Paul Muntner1, Raegan W Durant2, April P Carson1, Monika M Safford3, Emily B Levitan4.   

Abstract

BACKGROUND: Evidence is mixed regarding whether diabetes confers equivalent risk of coronary heart disease (CHD) as prevalent CHD. We investigated whether diabetes and severe diabetes are CHD risk equivalents.
METHODS: At baseline, participants in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study (black and white US adults ≥45 years old recruited in 2003-2007) were categorized as having prevalent CHD only (self-reported or electrocardiogram evidence; n = 3,043), diabetes only (self-reported or elevated glucose; n = 4,012), diabetes and prevalent CHD (n = 1,529), and neither diabetes nor prevalent CHD (n = 17,155). Participants with diabetes using insulin and/or with albuminuria (urinary albumin-to-creatinine ratio ≥30 mg/g) were categorized as having severe diabetes. Participants were followed up through 2011 for CHD events (myocardial infarction or fatal CHD).
RESULTS: During a mean follow-up of 5 years, 1,385 CHD events occurred. The hazard ratios of CHD events comparing participants with diabetes only, diabetes, and prevalent CHD and neither diabetes nor prevalent CHD with those with prevalent CHD were 0.65 (95% CI 0.54-0.77), 1.54 (95% CI 1.30-1.83), and 0.41 (95% CI 0.35-0.47), respectively, after adjustment for demographics and risk factors. Compared with participants with prevalent CHD, the hazard ratio of CHD events for participants with severe diabetes was 0.88 (95% CI 0.72-1.09).
CONCLUSIONS: Participants with diabetes had lower risk of CHD events than did those with prevalent CHD. However, participants with severe diabetes had similar risk to those with prevalent CHD. Diabetes severity may need consideration when deciding whether diabetes is a CHD risk equivalent.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27823692      PMCID: PMC5117821          DOI: 10.1016/j.ahj.2016.08.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  46 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Authors:  Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

3.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

4.  Comparative effectiveness research and outcomes of diabetes treatment.

Authors:  Monika M Safford
Journal:  JAMA       Date:  2014-06-11       Impact factor: 56.272

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

6.  Relation of increased hemoglobin A(1c) levels to severity of peripheral arterial disease in patients with diabetes mellitus.

Authors:  Wilbert S Aronow; Chul Ahn; Melvin B Weiss; Sateesh Babu
Journal:  Am J Cardiol       Date:  2007-04-05       Impact factor: 2.778

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction.

Authors:  Chong Do Lee; Aaron R Folsom; James S Pankow; Frederick L Brancati
Journal:  Circulation       Date:  2004-02-02       Impact factor: 29.690

9.  Association between urinary albumin excretion and coronary heart disease in black vs white adults.

Authors:  Orlando M Gutiérrez; Yulia A Khodneva; Paul Muntner; Dana V Rizk; William M McClellan; Mary Cushman; David G Warnock; Monika M Safford
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

10.  Does diabetes always confer coronary heart disease risk equivalent to a prior myocardial infarction?: implications for prevention.

Authors:  Edward J Boyko; James B Meigs
Journal:  Diabetes Care       Date:  2011-03       Impact factor: 19.112

View more
  10 in total

1.  Circulating Prolidase Activity in Patients with Myocardial Infarction.

Authors:  Adnan Sultan; Yuting Zheng; Patrick J Trainor; Yong Siow; Alok R Amraotkar; Bradford G Hill; Andrew P DeFilippis
Journal:  Front Cardiovasc Med       Date:  2017-07-31

2.  The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort.

Authors:  Baqiyyah N Conway; Xijing Han; Heather M Munro; Amy L Gross; Xiao-Ou Shu; Margaret K Hargreaves; Wei Zheng; Alvin C Powers; William J Blot
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

3.  The Impact of Type 2 Diabetes Mellitus on Long-Term Prognosis in Patients of Different Ages with Myocardial Infarction.

Authors:  S A Afanasiev; A A Garganeeva; E A Kuzheleva; A V Andriyanova; D S Kondratieva; S V Popov
Journal:  J Diabetes Res       Date:  2018-07-10       Impact factor: 4.011

4.  Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015.

Authors:  Robert S Rosenson; Lisandro D Colantonio; Greer A Burkholder; Ligong Chen; Paul Muntner
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

5.  Adherence to Statin Therapy Among US Adults Between 2007 and 2014.

Authors:  Lisandro D Colantonio; Robert S Rosenson; Luqin Deng; Keri L Monda; Yuling Dai; Michael E Farkouh; Monika M Safford; Kiran Philip; Katherine E Mues; Paul Muntner
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

6.  Association Between Caregiver Strain and Self-Care Among Caregivers With Diabetes.

Authors:  Alexandra King; Joanna Bryan Ringel; Monika M Safford; Catherine Riffin; Ronald Adelman; David L Roth; Madeline R Sterling
Journal:  JAMA Netw Open       Date:  2021-02-01

7.  Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.

Authors:  Demetria Hubbard; Lisandro D Colantonio; Robert S Rosenson; Todd M Brown; Elizabeth A Jackson; Lei Huang; Kate K Orroth; Stephanie Reading; Mark Woodward; Vera Bittner; Orlando M Gutierrez; Monika M Safford; Michael E Farkouh; Paul Muntner
Journal:  Cardiovasc Diabetol       Date:  2021-03-01       Impact factor: 9.951

8.  All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.

Authors:  M A Salinero-Fort; J Mostaza; C Lahoz; J Cárdenas-Valladolid; J I Vicente-Díez; P Gómez-Campelo; J M de Miguel-Yanes
Journal:  BMC Geriatr       Date:  2022-03-18       Impact factor: 3.921

9.  Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME Trial.

Authors:  Silvio E Inzucchi; Kamlesh Khunti; David H Fitchett; Christoph Wanner; Michaela Mattheus; Jyothis T George; Anne Pernille Ofstad; Bernard Zinman
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

10.  Levels of ankle-brachial index and the risk of diabetes mellitus complications.

Authors:  Lia Alves-Cabratosa; Marc Comas-Cufí; Anna Ponjoan; Maria Garcia-Gil; Ruth Martí-Lluch; Jordi Blanch; Marc Elosua-Bayes; Dídac Parramon; Lourdes Camós; Lidia Guzmán; Rafel Ramos
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.